ENL.AU Enlitic Inc

Healthcare Metals & Mining Australian Securities Exchange
0.0310 AUD
Close of Oct 31, 2026
0.0280 0.4500
Market cap
AUD 22.5M
P/E
-
P/B
3.90x
ROE
-328.0%
Dividend yield
-
Fundamental score
1.1/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is ENL.AU undervalued?

Graham number

The Graham number of Enlitic Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Enlitic Inc fundamental analysis

4 of 21 checks passed

ROE 0/2

Low return on equity (-328.0%), below 10%.

ROA 0/1

Return on assets (-149.3%) is below the industry median (-16.3%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (99.0%) is above the industry median (23.6%).

Revenue Growth 2/2

Revenue grew 61.8% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (21.8%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Cash Runway 0/2

Cash covers 0.2 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (3.9x) is above the industry median (1.5x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Enlitic Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Enlitic Inc

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization…

Full company profile